What is the relative risk of urologic malignancy in microscopic hematuria patients after negative evaluation? A long-term population-based retrospective analysis of 8465 patients.
Cystoscopy
Hematuria
Tomography
Urography
Urologic neoplasms
X-ray computed
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
25
07
2022
accepted:
23
12
2022
revised:
22
12
2022
pubmed:
3
1
2023
medline:
25
2
2023
entrez:
2
1
2023
Statut:
ppublish
Résumé
To evaluate whether microscopic hematuria (MH) patients with a negative initial evaluation have an elevated risk for urinary carcinoma. This is a population-based retrospective study with a matched control identified 8465 adults with an MH ICD code, an initial negative urinary malignancy work-up of cystoscopy and CT urography, and at least 35 months of clinical care. 8465 hematuria naïve controls were age, gender, and smoking status matched. Subsequent coding of non-prostatic urinary cancer, or any following hematuria codes: additional microscopic unspecified or unspecified hematuria, and gross hematuria was obtained. Χ There was no statistically significant difference in urinary malignancy rates (p > 0.05). Any urinary cancer: cases 0.74% (63/8465; 95% CI 0.58-0.95%)/controls 0.83% (71/8465; 95% CI 0.66-1.04%%) (p = 0.54); bladder: 0.45%/0.47% (p = 0.82); renal: 0.31%/0.38% (p = 0.43); ureteral: 0.01%/0.02% (p = 0.56). Subsequent gross hematuria in both males and females increased the odds of cancer: males 2.35 (p = 0.001; CI 1.42-3.91); females 4.25 (p < 0.001; CI 1.94-9.34). Males without additional hematuria had decreased odds ratio: 0.32 (p = 0.001; CI 0.16-0.64). Females without additional hematuria 0.58 (p = 0.19; CI 0.26-1.30) and both genders with additional unspecified hematuria/microscopic hematuria males 1.02 (p = 0.97; CI 0.50-2.08) and females 1.00 (p = 0.99; CI 0.38-2.66) did not have increased odds ratios (p > 0.05). MH patients with initial negative evaluation have a subsequent urologic malignancy rate of less than 1% and likely do not need further urinary evaluation unless they develop gross hematuria.
Identifiants
pubmed: 36592198
doi: 10.1007/s00261-022-03793-x
pii: 10.1007/s00261-022-03793-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1011-1019Informations de copyright
© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Références
Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU guideline. J Urol. 2020;204(4):778-786.
doi: 10.1097/JU.0000000000001297
pubmed: 32698717
Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. The Journal of urology. 2012 Dec;188(6S):2473-81.
doi: 10.1016/j.juro.2012.09.078
pubmed: 23098784
Madeb R, Golijanin D, Knopf J, et al. Long-term Outcome of Patients With a Negative Work-up for Asymptomatic Microhematuria. J Urol 2010;75(1):20-25.
doi: 10.1016/j.urology.2009.06.107
Pichler R, Heidbegger I, Leonhartsberger N, et al. The Need for Repeated Urological Evaluation in Low-risk Patients with Microscopic Hematuria After Negative Diagnostic Work-Up. Anticancer Res 2013; 33:5525-5530.
pubmed: 24324092
Mishriki SF, Nabi G, Cohen NP. Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years’ follow-up. Urology. 2008 Jan 1;71(1):13-6.
doi: 10.1016/j.urology.2007.08.031
pubmed: 18242356
Murakami S, Igarashi T, Hara S, Shimazaki J. Strategies for Asymptomatic Microscopic Hematuria: A Prospective Study of 1,034 Patients. J Urol 1990; 144:99-101.
doi: 10.1016/S0022-5347(17)39379-5
pubmed: 2193173
Wakui M, Shiigai T. Urinary tract cancer screening through analysis of urinary red blood cell volume distribution. International Journal of Urology. 2000 Jul;7(7):248-53.
doi: 10.1046/j.1442-2042.2000.00184.x
pubmed: 10910226
Howard RS, Golin AL. Long-term followup of asymptomatic microhematuria. The Journal of urology. 1991 Feb 1;145(2):335-6.
doi: 10.1016/S0022-5347(17)38331-3
pubmed: 1988725
Davides KC, King LM, and Jacobs D: Management of microscopic hematuria: twenty-year experience with 150 cases in a community hospital. Urology 28: 453–455, 1986.
doi: 10.1016/0090-4295(86)90142-1
pubmed: 3787916
Edwards TJ, Dickinson AJ, Gosling J,McInerney PD, Natale S, McGrath JS. Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up. BJU Int 2011;107:247–52.
doi: 10.1111/j.1464-410X.2010.09521.x
pubmed: 20726979
Smith MR, Read KC, Stegman ML, Kroll NJ, Van Every MJ. Evaluation of asymptomatic microscopic hematuria by renal ultrasound to detect upper tract malignancy: a 20-year experience in a community hospital. Urology. 2019 Nov 1;133:34-9.
doi: 10.1016/j.urology.2019.07.009
Rothmans K. Epidemiology: An Introduction, Oxford University Press, 2002:132.
Pak JS, Wang EY, Lee K, Pina LA, McKiernan JM, Anderson CB. Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial work-up. Urologic Oncology: Seminars and Original Investigations 2021 May 1;39 (5):300-e1.
doi: 10.1016/j.urolonc.2020.11.032
Jaffe JS, Ginsberg PC, Gill RA, Harkaway RC. A new diagnostic algorithm for the evaluation of microscopic hematuria. Urology. 2001 May 1;57(5):889-94.
doi: 10.1016/S0090-4295(00)01124-9
pubmed: 11337288
Ghandour R, Freifeld Y, Singla N, Lotan Y. Evaluation of hematuria in a large public health care system. Bladder Cancer. 2019 Jan 1;5(2):119-29.
doi: 10.3233/BLC-190221
pubmed: 31930164
pmcid: 6953989
Edwards TJ, Dickinson AJ, Natalie S, Gosling J, McGrath JS. A Prospective Analysis of the Diagnostic Yield Resulting From the Attendance of 4020 Patients at a Protocol-Driven Hematuria Clinic. BJU Int. 2006;97(2): 301-305.
doi: 10.1111/j.1464-410X.2006.05976.x
pubmed: 16430634
Yecies T, Bandari J, Fam M,Macleod L, Jacobs B, Davies B. Risk of Radiation from Computerized Tomography Urography in the Evaluation of Asymptomatic Microscopic Hematuria. J. Oncol 2018; 200:967-972.
Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A Prospective Analysis of 1,930 Patients with Hematuria to Evaluate Current Diagnostic Practice. J Urol 2000; 163:524-527.
doi: 10.1016/S0022-5347(05)67916-5
pubmed: 10647670